Literature DB >> 33431500

Covid-19: UK approves Moderna vaccine to be given as two doses 28 days apart.

Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2021        PMID： 33431500     DOI： 10.1136/bmj.n74

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE).

Authors:  Ai Phuong Tran; Daniel Tassone; Johannes Nossent; Nik Sheng Ding
Journal:  RMD Open       Date:  2022-05

Review 2.  Genomic variation, origin tracing, and vaccine development of SARS-CoV-2: A systematic review.

Authors:  Tianbao Li; Tao Huang; Cheng Guo; Ailan Wang; Xiaoli Shi; Xiaofei Mo; Qingqing Lu; Jing Sun; Tingting Hui; Geng Tian; Leyi Wang; Jialiang Yang
Journal:  Innovation (Camb)       Date:  2021-05-11

Review 3.  Applications of telemedicine in the supply and distribution of COVID-19 vaccines in Africa.

Authors:  Melody Okereke; Abdulhammed Opeyemi Babatunde; Samson Tobiloba Samuel; Isaac Olushola Ogunkola; Yidnekachew Girma Mogessie; Don Eliseo Lucero-Prisno
Journal:  J Glob Health       Date:  2021-03-01       Impact factor: 4.413

Review 4.  Coronavirus disease 2019 vaccine: An overview of the progression and current use.

Authors:  Safiye Gocer; Can Turk; Sukru Volkan Ozguven; Mehmet Doganay
Journal:  North Clin Istanb       Date:  2021-10-18

Review 5.  COVID-19 vaccination challenges: A mini-review.

Authors:  Zeinab Mohseni Afshar; Mohammad Barary; Rezvan Hosseinzadeh; Bardia Karim; Soheil Ebrahimpour; Kosar Nazary; Terence T Sio; Mark J M Sullman; Kristin Carson-Chahhoud; Emaduddin Moudi; Arefeh Babazadeh
Journal:  Hum Vaccin Immunother       Date:  2022-05-05       Impact factor: 4.526

6.  Assessing COVID-19 Booster Hesitancy and Its Correlates: An Early Evidence from India.

Authors:  Geetanjali C Achrekar; Kavita Batra; Yashashri Urankar; Ravi Batra; Naved Iqbal; Sabiha A Choudhury; Deepti Hooda; Roohi Khan; Suraj Arora; Aditi Singh; Francesco Chirico; Manoj Sharma
Journal:  Vaccines (Basel)       Date:  2022-06-30

Review 7.  COVID-19 pandemic: SARS-CoV-2 specific vaccines and challenges, protection via BCG trained immunity, and clinical trials.

Authors:  Wenping Gong; Ashok Aspatwar; Shuyong Wang; Seppo Parkkila; Xueqiong Wu
Journal:  Expert Rev Vaccines       Date:  2021-06-15       Impact factor: 5.217

8.  Molecular Docking and Dynamics Investigations for Identifying Potential Inhibitors of the 3-Chymotrypsin-like Protease of SARS-CoV-2: Repurposing of Approved Pyrimidonic Pharmaceuticals for COVID-19 Treatment.

Authors:  Amin Osman Elzupir
Journal:  Molecules       Date:  2021-12-09       Impact factor: 4.411

9.  Roles of existing drug and drug targets for COVID-19 management.

Authors:  Akeberegn Gorems Ayele; Engidaw Fentahun Enyew; Zemene Demelash Kifle
Journal:  Metabol Open       Date:  2021-06-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.